BioSpace News Archive

Business

Sorrento IDs Antibody Against COVID-19 That Appears 100% Effective

The company announced that one of its antibodies, STI-1499, has shown 100% inhibition of SARS-CoV-2 in laboratory tests.

May 15, 2020
·
5 min read
·
Mark Terry
Drug Development

Report: 16 COVID-19 Clinical Trials Showing Positive Results So Far

According to the World Health Organization and ClinicalTrials.gov, there are currently 1,114 ongoing clinical studies of treatments for COVID-19.

May 15, 2020
·
2 min read
·
Mark Terry
Drug Development

Pfizer Reports Promising Preliminary Results from Phase Ib DMD Gene Therapy Trial

The therapy demonstrated durable and statistically significant improvements in a number of efficacy endpoints measured 12 months after infusion.

May 15, 2020
·
3 min read
·
Mark Terry
Business

Lava Therapeutics and Janssen Biotech to Collaborate on Cancer Treatment Research

The goal is to discover and develop novel bispecific antibodies to gamma-delta T cells for the treatment of cancer.

May 15, 2020
·
3 min read
·
Krystle Vermes
Policy

FDA to Investigate False Negative Reports Related to Abbott’s Rapid COVID-19 Test

Following a study that raises concerns about the accuracy of Abbott’s rapid COVID-19 test for detecting the virus, the U.S. Food and Drug Administration (FDA) announced it will investigate the claims found in a New York University-related study as the company updates its guidance on the ID NOW test.

May 15, 2020
·
3 min read
·
Alex Keown
Policy

Biopharma Update on the Novel Coronavirus: May 15

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 15, 2020.

May 15, 2020
·
3 min read
·
BioSpace Editorial Staff
Business

Pandemic Delays Neurocrine’s Drug Launch for Parkinson’s Disease

With the COVID-19 pandemic closing physicians’ offices and causing patients to think twice about exposing themselves in healthcare settings, Neurocrine is delaying its launch of Ongentysis®.

May 15, 2020
·
4 min read
·
Gail Dutton
Pharm Country

With $20 Million, Immunai Emerges from Stealth Mode to Map Entire Immune System

The immune system mapping will play an important role in boosting R&D efforts in developing targeted therapies for different diseases.

May 15, 2020
·
2 min read
·
Alex Keown
Bio NC

Clinical Catch-Up: May 11-15

Clinical trial updates not related to COVID-19 are on the upswing, partly because some companies are announcing trial information ahead of the upcoming American Society of Clinical Oncology virtual meeting being held at the end of the month. Here’s a look.

May 15, 2020
·
12 min read
·
Mark Terry
Business

Sanofi Exec Takes Heat and Backpedals on Promise of U.S. Priority Access to COVID-19 Vaccine

Earlier this week, Sanofi’s chief executive officer Paul Hudson indicated that the U.S. would have first access to its COVID-19 vaccine because of the significant financial support it is receiving from the U.S. government.

May 15, 2020
·
3 min read
·
Mark Terry